Details of the Drug Reposition

General Information of This Drug (ID: DMCG4JG)

Drug Name
Solriamfetol   DMCG4JG
Synonyms
JZP-110; (R)-2-Amino-3-phenylpropyl carbamate; UNII-939U7C91AI; 939U7C91AI; (2R)-2-amino-3-phenylpropyl carbamate; Solriamfetol [USAN]; Adx-N05 free base; SCHEMBL2739637; O-Carbamoyl-(D)-phenylalaninol; UCTRAOBQFUDCSR-SECBINFHSA-N; ZINC34278783; (R)-2-amino-3-phenylpropyl carbamate; Benzenepropanol, beta-amino-, 1-carbamate, (betaR)-; Benzenepropanol, beta-amino-, carbamate (ester), (R)-; 178429-62-4
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Excessive daytime sleepiness DISI0RB1 MG42 Approved [1]
------------------------------------------------------------------------------------
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Narcolepsy DISLCNLI 7A20 Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)